April 15, 2019
Visicell Medical Team
According to a Nature article, the Japanese health ministry is expected to soon decide on a reprogrammed stem cell therapy for damage...
The FDA has stepped up its enforcement on unapproved therapies in many stem cell clinics across the United States. With false promise...
A partnership between Dan Kauffman, MD, PhD, at the Sanford Consortium of Regenerative Medicine, local biotech Fate Pharmaceuticals,...
Our Recent Posts
VisiCELL is presenting at 2020 Cell and Gene Meeting on the Mesa
October 16, 2020
A record year for biopharma M&A in 2019
January 14, 2020
Kicking off the Visicell Advisory Board with a bang!
November 24, 2019